Opexa Therapeutics (OPXA) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Join SI Premium – FREE
Opexa Therapeutics (NASDAQ: OPXA) reported Q2 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Walmart shares fall despite earnings beat
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
